Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - VYNE Therapeutics Inc. | tm2014909d1_ex99-2.htm |
| EX-99.1 - EXHIBIT 99.1 - VYNE Therapeutics Inc. | tm2014909d1_ex99-1.htm |
| 8-K/A - FORM 8-K/A - VYNE Therapeutics Inc. | tm2014909-1_8k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-229482) and Form S-8 (Nos. 333-222758, 333-229975 and 333-237041) of Menlo Therapeutics Inc. of our report dated March 12, 2020 relating to the financial statements of Foamix Pharmaceuticals Ltd., which appears in this Current Report on Form 8-K/A.
| Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
| May 7, 2020 | Certified Public Accountants (Isr.) |
| A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,
P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il